The UK Medicines and Healthcare products Regulatory Agency (MHRA) is issuing a patient alert card for men prescribed finasteride. The card is intended to raise awareness of the drug’s psychiatric side effects and sexual dysfunction, including the possibility that sexual dysfunction may continue after treatment is stopped.
Regulatorische Updates25. Aug. 2026•1 Min. Lesezeit
MHRA Introduces Patient Alert Card for Finasteride Users
A new patient alert card warns men on finasteride of psychiatric side effects and persistent sexual dysfunction.
Zusammengestellt vom PharmaCountry-Team · Quelle: MHRA
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen